←Back to Expert Scholars
Translational Medicine / 转化医学Lung Oncogenic Fusions
Robert Doebele
MD, PhD
🏢University of Colorado Anschutz🌐USA
Professor of Medicine
62
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Robert Doebele discovered key resistance mutations in ROS1 and NTRK fusion NSCLC. He co-founded Rain Therapeutics and has contributed to multiple fusion-directed drug development programs. His lab continues to identify novel fusion oncogenes.
Share:
🧪Research Fields 研究领域
ROS1 fusions
TRK inhibitors
Resistance mechanisms
Translational science
Fusion discovery
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robert Doebele 的研究动态
Follow Robert Doebele's research updates
留下邮箱，当我们发布与 Robert Doebele（University of Colorado Anschutz）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment